Bourse
Stock filings

TVTX insider trades & Congress trades

Travere Therapeutics, Inc.: public insider filings and Congress disclosures, in one place.

49insider buys + sells
0Congress trades
0 / 49insider buys / sells, 90 days
–latest buying cluster

Bourse has recorded 49 open-market insider transactions in Travere Therapeutics, Inc. (TVTX) (0 purchases with code P and 49 sales with code S), the most recent on October 15, 2026.

In the last 90 days: 0 purchases by 0 insiders ($0) and 49 sales by 9 ($80.1M).

Insider transactions

SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.

DateInsiderRoleTypeSharesPriceValueAfter 1M
Oct 15, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell128,065$52.97$6.78M–
Oct 15, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell37,270$54.20$2.02M–
Oct 15, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell78,400$55.02$4.31M–
Sep 17, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell101,691$64.59$6.57M–
Sep 17, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell6,802$64.95$442K–
Sep 17, 2026Heerma PeterEVP, CHIEF COMMERCIAL OFFICERSell8,282$65.07$539K–
Sep 16, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell99,716$63.26$6.31M−0.2%
Sep 16, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell96,125$63.64$6.12M−0.2%
Sep 16, 2026Rote William E.Chief Research OfficerSell65,104$63.12$4.11M−0.2%
Sep 16, 2026Rote William E.Chief Research OfficerSell47,746$63.61$3.04M−0.2%
Sep 16, 2026Heerma PeterEVP, CHIEF COMMERCIAL OFFICERSell93,604$63.25$5.92M−0.2%
Sep 16, 2026Heerma PeterEVP, CHIEF COMMERCIAL OFFICERSell79,113$63.65$5.04M−0.2%
Sep 15, 2026Cline Christopher R.CHIEF FINANCIAL OFFICERSell27,473$62.00$1.70M−0.2%
Sep 15, 2026Cline Christopher R.CHIEF FINANCIAL OFFICERSell20,735$62.61$1.30M−0.2%
Sep 15, 2026Cline Christopher R.CHIEF FINANCIAL OFFICERSell1,900$63.69$121K−0.2%
Sep 15, 2026Cline Christopher R.CHIEF FINANCIAL OFFICERSell400$65.31$26K−0.2%
Sep 15, 2026Calvin SandraSVP, CHIEF ACCOUNTING OFFICERSell4,275$62.14$266K−0.2%
Sep 15, 2026Calvin SandraSVP, CHIEF ACCOUNTING OFFICERSell800$62.85$50K−0.2%
Sep 15, 2026Calvin SandraSVP, CHIEF ACCOUNTING OFFICERSell300$63.66$19K−0.2%
Sep 15, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell63,498$61.99$3.94M−0.2%
Sep 15, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell28,796$62.66$1.80M−0.2%
Sep 15, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell3,102$63.64$197K−0.2%
Sep 15, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSell270$65.31$18K−0.2%
Sep 15, 2026Reed Elizabeth EChief Legal Officer and GCSell21,926$62.03$1.36M−0.2%
Sep 15, 2026Reed Elizabeth EChief Legal Officer and GCSell13,874$62.63$869K−0.2%
Sep 15, 2026Reed Elizabeth EChief Legal Officer and GCSell1,400$63.69$89K−0.2%
Sep 15, 2026Reed Elizabeth EChief Legal Officer and GCSell300$65.31$20K−0.2%
Sep 15, 2026Inrig JulaEVP, Head of R&D & CMOSell25,390$62.02$1.57M−0.2%
Sep 15, 2026Inrig JulaEVP, Head of R&D & CMOSell17,284$62.62$1.08M−0.2%
Sep 15, 2026Inrig JulaEVP, Head of R&D & CMOSell1,600$63.69$102K−0.2%

Showing the 30 most recent of 49 transactions.

Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.

New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.

See these filings as they land

Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.

Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.